Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-25-000074
Filing Date
2025-05-13
Accepted
2025-05-13 16:31:41
Documents
88
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20250331.htm   iXBRL 10-Q 819594
2 EX-10.3 elicio-amendedandrestate.htm EX-10.3 10169
3 EX-31.1 elicio10-qxexhibit311.htm EX-31.1 4380
4 EX-31.2 elicio10-qxexhibit312.htm EX-31.2 4404
5 EX-32.1 elicio10-qxexhibit321.htm EX-32.1 1615
6 EX-32.2 elicio10-qxexhibit322.htm EX-32.2 1642
12 elicio-amendedandrestate001.jpg GRAPHIC 251761
13 elicio-amendedandrestate002.jpg GRAPHIC 264580
14 elicio-amendedandrestate003.jpg GRAPHIC 123808
15 elicio10-qxexhibit311001.jpg GRAPHIC 225649
16 elicio10-qxexhibit311002.jpg GRAPHIC 66163
17 elicio10-qxexhibit312001.jpg GRAPHIC 225553
18 elicio10-qxexhibit312002.jpg GRAPHIC 68346
19 elicio10-qxexhibit321001.jpg GRAPHIC 95284
20 elicio10-qxexhibit322001.jpg GRAPHIC 97486
  Complete submission text file 0001601485-25-000074.txt   7714669

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20250331.xsd EX-101.SCH 47774
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20250331_cal.xml EX-101.CAL 58326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20250331_def.xml EX-101.DEF 227438
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20250331_lab.xml EX-101.LAB 604358
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20250331_pre.xml EX-101.PRE 453397
91 EXTRACTED XBRL INSTANCE DOCUMENT angn-20250331_htm.xml XML 581902
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 25940675
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)